Congratulations to our friends at Abeona Therapeutics Inc. (ABEO), a leading clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, who were invited to visit the Nasdaq MarketSite in Times Square to raise awareness for Rare Disease Day this year.

In honor of the occasion, Timothy J. Miller, Ph.D., President and Chief Executive Officer, rang the Closing Bell. 

Leave a Reply

Your email address will not be published.

X